NCT01747304

Brief Summary

DXA scanners are routinely used to assess bone mineral density (BMD) and fracture risk in osteoporosis patients. They provide detailed bone imaging in a low radiation setting. Hologic manufactures scanners that are able to perform high definition instant vertebral fracture assessment (HD-IVA) used to screen at-risk patients for asymptomatic spine fractures instantly and reliably at the same time they are having their yearly BMD. We wish to investigate whether this same proven technology (HD-IVA scan mode) used on femurs (the scan mode is now called SE Femur scans) can be used to screen for atypical fractures of the femur in patients at risk for these debilitating fractures. In this proof of concept study, we propose to examine whether DXA scanners can provide a sensitive low radiation screening method to identify incomplete AFFs in patients with known incomplete AFFs and in patients at risk.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
285

participants targeted

Target at P75+ for all trials

Timeline
4mo left

Started Jul 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Jul 2012Dec 2026

Study Start

First participant enrolled

July 1, 2012

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 7, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 11, 2012

Completed
14 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

August 19, 2025

Status Verified

August 1, 2025

Enrollment Period

14.4 years

First QC Date

December 7, 2012

Last Update Submit

August 13, 2025

Conditions

Keywords

Atypical Femur FractureDXA

Outcome Measures

Primary Outcomes (1)

  • HD-IVA visualization of incomplete femur fractures

    Hologic DXA scanner using the high-definition IVA (HD-IVA) mode on femur bones will be able to visualize incomplete femur fractures at least 90% of the time in patients with known incomplete AFF.

    1 day (one time point )

Study Arms (3)

Screening population

Healthy post-menopausal women attending bone mineral density screening clinic with leg/hip/groin pain/discomfort/weakness an has been on anti-resorptive therapy for at least 5 years.

Device: DXA Se femur scans (previously called IVA femur)

Comparator Group

Control group from Toronto CaMOS cohort willing to participate.

Device: DXA Se femur scans (previously called IVA femur)

AFF group

participants in the AFF Cohort study at UHN

Device: DXA Se femur scans (previously called IVA femur)

Interventions

Single Energy Beam (previously called inter-vertebral assessment) by Dual energy x-ray absorptiometry of affected femur

Also known as: SF Femur scans
AFF groupComparator GroupScreening population

Eligibility Criteria

Age18 Years - 100 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Osteoporosis/Bone Mineral Density Lab out-patients

You may qualify if:

  • Known AFF group
  • A subject must have experienced an incomplete atypical low trauma fracture of the femoral shaft;
  • Is a patient at the UHN osteoporosis clinic.
  • Comparison Group
  • Must be scheduled for a bone mineral density scan at UHN
  • Have been on any bisphosphonate for 5 years or longer, and;
  • Have unexplained symptoms of leg, hip, thigh, or knee pain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Health Network

Toronto, Ontario, M5G 2C4, Canada

Location

Study Officials

  • Angela M Cheung, MD, PhD, CCD

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2012

First Posted

December 11, 2012

Study Start

July 1, 2012

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 19, 2025

Record last verified: 2025-08

Locations